Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 146

1.

Combination of second-line antirheumatic drugs.

Haagsma CJ, van Riel PL.

Ann Med. 1997 Apr;29(2):169-73. Review.

PMID:
9187235
2.

Combining sulphasalazine and methotrexate in rheumatoid arthritis: early clinical impressions.

Haagsma CJ, van Riel PL, van de Putte LB.

Br J Rheumatol. 1995 Nov;34 Suppl 2:104-8. Review.

PMID:
8535640
3.

Rational use of new and existing disease-modifying agents in rheumatoid arthritis.

Kremer JM.

Ann Intern Med. 2001 Apr 17;134(8):695-706. Review.

PMID:
11304108
4.

Treatment of rheumatoid arthritis with methotrexate alone, sulfasalazine and hydroxychloroquine, or a combination of all three medications.

O'Dell JR, Haire CE, Erikson N, Drymalski W, Palmer W, Eckhoff PJ, Garwood V, Maloley P, Klassen LW, Wees S, Klein H, Moore GF.

N Engl J Med. 1996 May 16;334(20):1287-91.

5.

Disease-modifying antirheumatic drugs.

Conaghan PG, Lehmann T, Brooks P.

Curr Opin Rheumatol. 1997 May;9(3):183-90. Review.

PMID:
9204252
6.

Combination therapy with disease modifying anti-rheumatic drugs in rheumatoid arthritis.

Garrood T, Scott DL.

BioDrugs. 2001;15(8):543-61. Review.

PMID:
11543695
8.

[Rational therapeutic approach in rheumatoid arthritis].

Tłustochowicz W.

Ann Acad Med Stetin. 2006;52 Suppl 2:5-10. Review. Polish.

PMID:
17471832
9.

Triple therapy in early active rheumatoid arthritis: a randomized, single-blind, controlled trial comparing step-up and parallel treatment strategies.

Saunders SA, Capell HA, Stirling A, Vallance R, Kincaid W, McMahon AD, Porter DR.

Arthritis Rheum. 2008 May;58(5):1310-7. doi: 10.1002/art.23449.

10.

[Combination therapy with remission-inducing drugs in chronic polyarthritis: 1996 update].

Wollin D, Menninger H.

Z Rheumatol. 1997 May-Jun;56(3):114-26. Review. German.

PMID:
9340952
11.

The rheumatoid arthritis patient in the clinic: comparing more than 1,300 consecutive DMARD courses.

Aletaha D, Smolen JS.

Rheumatology (Oxford). 2002 Dec;41(12):1367-74.

PMID:
12468815
12.
13.
14.

Disease-modifying antirheumatic drugs, including methotrexate, gold, antimalarials, and D-penicillamine.

Conaghan PG, Brooks P.

Curr Opin Rheumatol. 1995 May;7(3):167-73. Review.

PMID:
7612407
15.

[Basic therapeutic combination therapy in chronic polyarthritis: an overview].

Menninger H.

Z Rheumatol. 1998 Feb;57(1):25-30. Review. German.

PMID:
9566103
16.

History of combination therapy of rheumatoid arthritis.

Paulus HE.

J Rheumatol Suppl. 1996 Mar;44:38-42.

PMID:
8833050
17.

Combination therapy with multiple disease-modifying antirheumatic drugs in rheumatoid arthritis: a preventive strategy.

Pincus T, O'Dell JR, Kremer JM.

Ann Intern Med. 1999 Nov 16;131(10):768-74. Review.

PMID:
10577301
18.

A meta-analysis of the efficacy and toxicity of combining disease-modifying anti-rheumatic drugs in rheumatoid arthritis based on patient withdrawal.

Choy EH, Smith C, Doré CJ, Scott DL.

Rheumatology (Oxford). 2005 Nov;44(11):1414-21. Epub 2005 Jul 19. Review.

PMID:
16030080
19.

[Evidence-based treatment of methotrexate-resistant rheumatoid arthritis. Combinations of conventional disease-modifying antirheumatic agents].

Schnabel A, Gross WL.

Dtsch Med Wochenschr. 2003 Jan 24;128(4):147-9. German. No abstract available.

PMID:
12589584
20.

The role of anti-malarials in rheumatoid arthritis--the American experience.

Khraishi MM, Singh G.

Lupus. 1996 Jun;5 Suppl 1:S41-4. Review.

PMID:
8803910

Supplemental Content

Support Center